The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Creatine monohydrate in DM2/PROMM: A double-blind placebo-controlled clinical study
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinical studies with CrM have been largely positive in DMD/BMD [177,178,201], equivocal in myotonic dystrophy (type I and II) [202–204], and positive in mixed myopathy populations [201,205].”
From Creatine monohydrate supplementation for older adults and clinical populations (2025) · cites this paper as [202]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation
Harris, R. C., Söderlund, K., & Hultman, E. (1992) · Clinical Science · doi:10.1042/cs0830367 · Cited by 1,168
Tarnopolsky, M. A., & MacLennan, D. P. (2000) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.10.4.452 · Cited by 113
Research works printed but not linked: 8
- 10.1016/S0960-8966(01)00284-X · DOI
- Liquori CL, Ricker K, Moseley ML, et al. Myotonic dystrophy type 2 is caused by a CCTG repeat expansion in intron 1 of ZNF9. Science . 2001; 239: 864–867.
- 10.1212/WNL.52.4.854 · DOI · Paper page
- 10.1212/WNL.54.9.1848 · DOI · Paper page
- Tarnopolsky MA, Parise G. Direct measurement of high energy phosphate compounds in patients with neuromuscular diseases. Muscle Nerve . 1999; 22: 1502–1509.
- 10.1002/mus.1055 · DOI · Paper page
- Persky AM, Brazeau GA. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev . 2001; 53: 161–176. · DOI · Paper page
- 10.1016/S0960-8966(01)00273-5 · DOI · Paper page
Cited by
Creatine for treating muscle disorders
Kley, R. A., Tarnopolsky, M. A., & Vorgerd, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004760.pub4 · Cited by 169
Exploring the therapeutic role of creatine supplementation
Gualano, B., Artioli, G. G., Poortmans, J. R., & Lancha Junior, A. H. (2010) · Amino Acids · doi:10.1007/s00726-009-0263-6 · Cited by 156
Clinical Use of Creatine in Neuromuscular and Neurometabolic Disorders
Tarnopolsky, M. A. (2007) · Subcellular Biochemistry · doi:10.1007/978-1-4020-6486-9_10 · Cited by 67
Creatine for treating muscle disorders
Kley, R. A., Vorgerd, M., & Tarnopolsky, M. A. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004760.pub2 · Cited by 45
Creatine monohydrate supplementation for older adults and clinical populations
Candow, D. G., Ostojic, S. M., Chilibeck, P. D., Longobardi, I., Gualano, B., Tarnopolsky, M. A., Wallimann, T., Moriarty, T., Kreider, R. B., Forbes, S. C., et al. (2025) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2025.2534130 · Cited by 43
Creatine for treating muscle disorders
Kley, R. A., Tarnopolsky, M. A., & Vorgerd, M. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004760.pub3 · Cited by 38
Metadata
- Authors
- Schneider–Gold, C., Beck, M., Wessig, C., George, A., Kele, H., Reiners, K., & Toyka, K. V.
- Affiliations
- From the Department of Neurology (Drs. Schneider–Gold, Beck, Wessig, George, Reiners, and Toyka), University of Würzburg; and Department of Clinical Neurophysiology (Dr. Kele), University of Göttingen, Germany.
- Venue
- Neurology
- Published
- 2003-02-11
- Volume
- 60
- Issue
- 3
- Pages
- 500-502
- ISSN
- 0028-3878
- 1526-632X
- Cited by
- 35
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.